Advanced oxidation protein products: A novel marker of oxidative stress in ulcerative colitis

Journal of Clinical Gastroenterology

Volumn 42, Issue 6, 2008, Pages 687-691

  Baskol, Mevlut ^a   Baskol, Gulden ^a   Koçer, Derya ^a   Ozbakir, Omer ^a   Yucesoy, Mehmet ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Aoxidative stress; Ulcerative colitis advanced oxidation protein products

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; BIOLOGICAL MARKER; LIPID; MALONALDEHYDE; MESALAZINE; THIOL; PEROXIDASE; PLASMA PROTEIN; THIOL DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HUMAN; LEUKOCYTE ACTIVATION; LIPID PEROXIDATION; MALE; NEUTROPHIL; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; ULCERATIVE COLITIS; ADOLESCENT; BLOOD; HOSPITALIZATION; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PROTEINS; COLITIS, ULCERATIVE; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; NEUTROPHIL ACTIVATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIDASE; SEVERITY OF ILLNESS INDEX; SULFHYDRYL COMPOUNDS;

EID: 54749127429     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318074f91f     Document Type: Article

References (41)

1. Sartor RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol. 1997;92(suppl 12): 5S-11S.
2. Nikolaus S, Bauditz J, Gionchetti P, et al. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut. 1998;42:470-476.
3. Kucharzik T, Walsh SV, Chen J, et al. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol. 2001;159: 2001-2009.
4. Jewell DP. Ulcerative colitis. In: Sleisenger MH, Fordtran JS, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. Philadelphia: WB Saunders Company; 1998:1305-1330.
5. Schreiber S, Raedler A, Stenson WF, et al. The role of the mucosal immune system in inflammatory bowel disease. Gastroenterol Clin North Am. 1992;21:451-502.
6. Keshavarzian A, Price YE, Peters AM, et al. Specificity of III-Indium granulocyte scanning and fecal excretion measurement - An auto radiographic study. Dig Dis Sci. 1985;30:1156-1160.
7. Grisham MB, Granger DN. Neutrophil-mediated mucosal injury: role of reactive oxygen metabolites. Dig Dis Sci. 1988;33(suppl 3): 6S-15S.
8. Odajima T, Onishi M. Biological significance and mechanisms of reactions and events mediated by myeloperoxidase in the xenobiotic metabolism and disposition pathways of leucocytes. Med Sci Res. 1998; 26:291-298.
9. Lampert MB, Weiss SJ. The chlorinating potential of the human monocyte. Blood. 1983;62:645-651.
10. Hawkins CL, Davies MJ. Hypochlorite-induced damage to proteins: formation of nitrogen-centred radicals from lysine residues and their role in protein fragmentation. Biochem J. 1998;332: 617-625.
11. Hazen SL, Hsu FF, d'Avignon A, et al. Human neutrophils employ myeloperoxidase to convert α-amino acids to a battery of reactive aldehydes: a pathway for aldehyde generation at sites of inflammation. Biochemistry 1998;37:6864-6873.
12. Hazen SL, Hsu FF, Duffin K, et al. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols. J Biol Chem. 1996;271:23080-23088.
13. Prutz WA. Hypochlorous acid interactions with thiols, nucleotides, DNA, and other biological substrates. Arch Biochem Biophys. 1996;332: 110-120.
14. Oshitani N, Kitano A, Okabe H, et al. Location of superoxide anion generation in human colonic mucosa obtained by biopsy. Gut. 1993; 34:936-938.
15. Parks DA. Oxygen radicals: mediators of gastrointestinal patho-physiology. Gut. 1989;30:293-298.
16. Cadenas E. Biochemistry of oxygen toxicity. Annu Rev Biochem. 1989; 58:79-110.
17. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med. 1991;91:14-22.
18. Draper HH, Hadley MA. Review of recent studies on the metabolism of exogenous and endogenous malondialdehyde. Xenobiotica. 1990;20:901-907.
19. Romero FJ, Bosch-Morell F, Romero MJ, et al. Lipid peroxidation products and antioxidants in human disease. Environl Health Perspect. 1998;106:1229-1234.
20. Rumley AG, Paterson JR. Analytical aspects of antioxidants and free radical activity in clinical biochemistry. Ann Clin Biochem. 1998;35:181-200.
21. Kruidenier L, Kuiper I, Van Duijn W, et al. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol. 2003;201:17-27.
22. Koch TR, Yuan LX, Stryker SJ, et al. Total antioxidant capacity of colon in patients with chronic ulcerative colitis. Dig Dsi Sci. 2000;45: 1814-1819.
23. Keshavarzian A, Banan A, Farhadi A, et al. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut. 2003;52:720-728.
24. Nieto N, Torres MI, Fernandez MI, et al. Experimental ulcerative colitis impairs antioxidant defense system in rat intestine. Dig Dis Sci. 2000;45:1820-1827.
25. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49:1304-1313.
26. Witko-Sarsat V, Friedlander M, Nguyen Khoa T, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 1998;161: 2524-2532.
27. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. BMJ. 1955;29:1041-1048.
28. Farrell RJ, Peppercom MA. Endoscopy in inflammatory bowel disease. In: Sartor BR, Sandborn WJ, eds. Kirsner's Inflammatory Bowel Diseases. 6th ed. New York: Saunders; 2004:380-398.
29. Bradley PP, Priebat DA, Christensen RD, et al. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78:206-209.
30. Witko V, Nguyen AT, Descamps-Latscha B. Microtiter plate assay for phagocyte-derived taurine-chloramines. J Clin Lab Anal. 1992;6:47-53.
31. Jain SK. Evidence for membrane lipid peroxidation during the in vivo aging of human erythrocytes. Biochem Biophys Acta. 1988;937: 205-210.
32. Hu ML, Louie S, Cross CE, et al. Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med. 1993;121: 257-262.
33. Kruidenier L, Verspaget HW. Oxidative stress as a pathogenic factor in inflammatory bowel disease-radical or ridiculous? Aliment Pharmacol Ther. 2002;16:1997-2015.
34. Simmonds NJ, Allen RE, Stevens TR, et al. Chemiluminescence assay of mucosal reactive oxygen metabolite in inflammatory bowel disease. Gastroenterology. 1992;103:186-196.
35. Witko-Sarsat V, Nguyen-Khoa T, Jungers P, et al. Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia. Nephrol Dial Transplant. 1999;14:76-78.
36. Witko-Sarsat V, Nguyen-Khoa T, Canteloup S, et al. Advanced oxidation protein products (AOPP) as novel mediators between neutrophils and monocytes in chronic renal failure (CRF). J Am Soc Nephrol. 1997;8:488A.
37. Yazici C, Kose K, Calis M, et al. Protein oxidation status in patients with ankylosing spondylitis. Rheumatology. 2004;43:1235-1239.
38. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol. 1997; 82:291-295.
39. Halliwell B, Gutteridge JMC. Protection against oxidants in biological systems: the superoxide therapy of oxygen toxicity. In: Halliwell B, Gutteridge JMC, eds. Free Radicals in Biology and Medicine. 2nd ed. Oxford: Clarendon Press; 1996: 86-130.
40. Halliwell B, Gutteridge JMC. Lipid peroxidation: a radical chain reaction. In: Halliwell B, Gutteridge JMC, eds. Free Radicals in Biology and Medicine. 2nd ed. Oxford: Clarendon Press; 1996: 188-276.
41. Pullar T, Zoma A, Capell HA, et al. Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulphasalazine. Br J Rheumatol. 1987;26:202-206.